BR-1018-2

N/A

Report date: 2022/08/09 20:00:46

Base Information

Drug NameBR-1018-2
Drug Alias NameBR-1018-2
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperlipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A